Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

MyoKardia
455 Mission Bay Blvd South, Suite 575
San Francisco, CA 94158
Phone: 415-766-3638
www.myokardia.com

MyoKardia is dedicated to revolutionizing the treatment of genetic cardiovascular disease. The company's proprietary platform combines recent breakthroughs in muscle biology with leading-edge cardiovascular disease genetics. This personalized, genetically targeted approach focuses on the underlying cause of disease and has the potential to drastically improve the treatment of cardiomyopathies, and ultimately a broader spectrum of cardiovascular disease, including heart failure. Founded by world leaders in muscle biology and cardiovascular disease genetics, MyoKardia was launched in 2012 with funding from leading life sciences investor, Third Rock Ventures

Key Contact
Name
Charles Homcy
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
09/20/12 $38,000,000 Series A Third Rock Ventures
undisclosed


Featured Reading